Inactive Instrument

Asia Pacific Silk Road Investment Co Ltd Stock Hong Kong S.E.

Equities

0767

BMG6853V2817

Consumer Lending

Sales 2021 81.89M 10.46M Sales 2022 100M 12.81M Capitalization 179M 22.84M
Net income 2021 6M 766K Net income 2022 - 0 EV / Sales 2021 9.79 x
Net Debt 2021 419K 53.51K Net cash position 2022 48.31M 6.17M EV / Sales 2022 1.3 x
P/E ratio 2021
518 x
P/E ratio 2022
-198 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 59.52%
More Fundamentals * Assessed data
Dynamic Chart
Zhong Ji Guan De Biological Technology (HK) Limited and Qingcheng County Branch of Gansu Alcon Bioengineering Company Limited Enter into the Biological Product Trading Contract CI
Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhong Ji Longevity Science to Form JV with Chengdu Guandetang Biotechnology MT
Zhong Ji Longevity Science's Unit Authorizes Eternal Asia as Distributor of Longevity Biological Product; Shares Jump 4% MT
Zhong Ji Longevity Questions Reliability of Reports About Troubled Day Procedure Centre MT
Zhong Ji Longevity's H1 Attributable Profit Falls as Health Product Sales Plunge MT
Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhong Ji Longevity Science Shareholders to Vote on 10-for-1 Share Consolidation MT
Zhong Ji Longevity Science Taps LBJ (Hong Kong) for Product Distribution MT
Zhong Ji Longevity Science Group Limited Enters into Strategic Cooperation Framework Agreement with LJ (Hong Kong) Co., Limited CI
Zhong Ji Longevity Science Group Limited Announces Change of Company Secretary CI
Zhong Ji Longevity Science Group Raises HK$14 Million Via Share Issuance MT
Zhong Ji Longevity Science to Raise HK$14 Million in Share Placement; Shares Climb 3% MT
Zhong Ji Longevity Science's Share Placement Will Not Proceed MT
Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.
More about the company